Literature DB >> 22422472

Alternative approaches to modeling hereditary dystonias.

Rachel Fremont1, Kamran Khodakhah.   

Abstract

Dystonia is a movement disorder characterized by involuntary muscle contractions resulting in abnormal postures. Although common in the clinic, the etiology of dystonia remains unclear. Most dystonias are idiopathic and are not associated with clear pathological brain abnormalities. Attempts to genetically model these dystonias in rodents have failed to replicate dystonic symptoms. This is at odds with the fact that rodents can exhibit dystonia. Because of this discrepancy, it is necessary to consider alternative approaches to generate phenotypically and genotypically faithful models of dystonia. Conditional knockout of dystonia-related genes is 1 technique that may prove useful for modeling genetic dystonias. Lentiviral-mediated small or short hairpin RNA (shRNA) knockdown of particular genes is another approach. Finally, in cases in which the function of a dystonia-related gene is well-known, pharmacological blockade of the protein product can be used. Such an approach was successfully implemented in the case of rapid-onset dystonia parkinsonism, DYT12. This (DYT12) is a hereditary dystonia caused by mutations in the α₃ isoform of the sodium potassium adenosine triphosphatase (ATPase) pump (sodium pump), which partially hampers its physiological function. It was found that partial selective pharmacological block of the sodium pumps in the cerebellum and basal ganglia of mice recapitulates all of the salient features of DYT12, including dystonia and parkinsonism induced by stress. This DYT12 model is unique in that it faithfully replicates human symptoms of DYT12, while targeting the genetic cause of this disorder. Acute disruption of proteins implicated in dystonia may prove a generally fruitful method to model dystonia in rodents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22422472      PMCID: PMC3337017          DOI: 10.1007/s13311-012-0113-1

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  98 in total

1.  Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia.

Authors:  Mai T Dang; Fumiaki Yokoi; Kevin St P McNaught; Toni-Ann Jengelley; Tehone Jackson; Jianyong Li; Yuqing Li
Journal:  Exp Neurol       Date:  2005-10-20       Impact factor: 5.330

2.  Functional MRI reveals activation of a subcortical network in a 5-year-old girl with genetically confirmed myoclonus-dystonia.

Authors:  M F Nitschke; C Erdmann; P Trillenberg; A Sprenger; N Kock; J Sperner; C Klein
Journal:  Neuropediatrics       Date:  2006-04       Impact factor: 1.947

Review 3.  Lentiviral vectors for use in the central nervous system.

Authors:  Johan Jakobsson; Cecilia Lundberg
Journal:  Mol Ther       Date:  2006-01-03       Impact factor: 11.454

4.  Neuroimaging in human dystonia.

Authors:  Kotaro Asanuma; Maren Carbon-Correll; David Eidelberg
Journal:  J Med Invest       Date:  2005-11

5.  Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope.

Authors:  Rose E Goodchild; Connie Eunji Kim; William T Dauer
Journal:  Neuron       Date:  2005-12-22       Impact factor: 17.173

6.  Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice.

Authors:  Fumiaki Yokoi; Mai Tu Dang; Jianyong Li; Yuqing Li
Journal:  J Biochem       Date:  2006-06-30       Impact factor: 3.387

7.  The THAP domain of THAP1 is a large C2CH module with zinc-dependent sequence-specific DNA-binding activity.

Authors:  Thomas Clouaire; Myriam Roussigne; Vincent Ecochard; Catherine Mathe; François Amalric; Jean-Philippe Girard
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-29       Impact factor: 11.205

Review 8.  Neuronal function and alpha3 isoform of the Na/K-ATPase.

Authors:  Maxim Dobretsov; Joseph R Stimers
Journal:  Front Biosci       Date:  2005-09-01

9.  Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson's disease and normal macaque.

Authors:  Philip A Starr; Geoff M Rau; Valerie Davis; William J Marks; Jill L Ostrem; Donn Simmons; Nadja Lindsey; Robert S Turner
Journal:  J Neurophysiol       Date:  2005-02-09       Impact factor: 2.714

Review 10.  Rodent models for dystonia research: characteristics, evaluation, and utility.

Authors:  H A Jinnah; Ellen J Hess; Mark S Ledoux; Nutan Sharma; Mark G Baxter; Mahlon R Delong
Journal:  Mov Disord       Date:  2005-03       Impact factor: 10.338

View more
  5 in total

1.  Animal models of neurological disorders.

Authors:  Marie-Francoise Chesselet; S Thomas Carmichael
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

2.  Enhanced inhibitory neurotransmission in the cerebellar cortex of Atp1a3-deficient heterozygous mice.

Authors:  Keiko Ikeda; Shin'Ichiro Satake; Tatsushi Onaka; Hiroki Sugimoto; Naoki Takeda; Keiji Imoto; Kiyoshi Kawakami
Journal:  J Physiol       Date:  2013-05-07       Impact factor: 5.182

3.  Aberrant Purkinje cell activity is the cause of dystonia in a shRNA-based mouse model of Rapid Onset Dystonia-Parkinsonism.

Authors:  Rachel Fremont; Ambika Tewari; Kamran Khodakhah
Journal:  Neurobiol Dis       Date:  2015-06-17       Impact factor: 5.996

Review 4.  Dystonia and Paroxysmal Dyskinesias: Under-Recognized Movement Disorders in Domestic Animals? A Comparison with Human Dystonia/Paroxysmal Dyskinesias.

Authors:  Angelika Richter; Melanie Hamann; Jörg Wissel; Holger A Volk
Journal:  Front Vet Sci       Date:  2015-11-30

5.  Acute cerebellar knockdown of Sgce reproduces salient features of myoclonus-dystonia (DYT11) in mice.

Authors:  Samantha Washburn; Rachel Fremont; Maria Camila Moreno-Escobar; Chantal Angueyra; Kamran Khodakhah
Journal:  Elife       Date:  2019-12-23       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.